SARCode Secures $44,000,000 Series B Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    1000 Marina Boulevard Brisbane, CA 94005
  • Company Description
    SARcode is a private, San Francisco based company focused on the development of small molecule LFA-1 inhibitors to treat inflammatory diseases.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds from the Series B financing will largely support further clinical development of SAR 1118, SARcode’s lead compound for the treatment of dry eye syndrome.
  • M&A Terms
  • Venture Investor
    Sofinnova Ventures
  • Venture Investor
    Rho Ventures
  • Venture Investor
    Alta Partners
  • Venture Investor
    Clarus Ventures